Priralfinamide
- Generic Name
- Priralfinamide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H19FN2O2
- CAS Number
- 133865-88-0
- Unique Ingredient Identifier
- 3LPF0S0GVV
- Indication
Investigated for use/treatment in pain (acute or chronic).
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2017-09-15
- Lead Sponsor
- Newron Pharmaceuticals SPA
- Target Recruit Count
- 411
- Registration Number
- NCT01019824
- Locations
- 🇬🇧
Parexel, London, England, United Kingdom
Phase II Dose Titration Study in Patients With Neuropathic Pain
- First Posted Date
- 2008-08-15
- Last Posted Date
- 2009-08-07
- Lead Sponsor
- Newron Pharmaceuticals SPA
- Target Recruit Count
- 272
- Registration Number
- NCT00736151
- Locations
- 🇦🇹
Universitatsklinik Fur Neurologie, Innsbruck, Austria
🇨🇿Fakultni nemocnice Brno, Brno-Bhunice, Czech Republic
🇨🇿Fakultni Thomayerova nemocnices poliklinikou, Praha, Czech Republic
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath